Eli Lilly
Trade Eli Lilly 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About LLY
Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products consist of diabetes, oncology, immunology, neuroscience, and other products and therapies.
LLY Key Statistics
Stock Snapshot
The current Eli Lilly(LLY) stock price is $875.00, with a market capitalization of 829.24B. The stock trades at a price-to-earnings (P/E) ratio of 38.27 and offers a dividend yield of 70.9%.
As of 2026-03-30, Eli Lilly(LLY) stock has fluctuated between $872.51 and $901.15. The current price stands at $875.00, placing the stock +0.3% above today's low and -2.9% off the high.
Eli Lilly(LLY) shares are trading with a volume of 2.74M, against a daily average of 3.1M.
During the past year, Eli Lilly(LLY) stock moved between $623.78 at its lowest and $1,133.95 at its peak.
During the past year, Eli Lilly(LLY) stock moved between $623.78 at its lowest and $1,133.95 at its peak.
LLY News
The partnership is the latest in a string of tie-ups between pharma majors and Chinese companies. Bloomberg News Eli Lilly LLY -2.09 %decrease; red down pointi...
Insilico Medicine announced a drug discovery collaboration with Eli Lilly (LLY) and Company that uses Insilico’s AI engine to accelerate the discovery and devel...
Eli Lilly & Co. (NYSE:LLY) has reportedly finalized a $2.75 billion agreement to introduce AI-developed drugs from Hong Kong’s Insilico Medicine to the global m...
Analyst ratings
83%
of 35 ratingsMore LLY News
...
(RTTNews) - InSilico Medicine Cayman TopCo (3696.HK) announced that it has entered into a licensing and drug discovery collaboration with Eli Lilly and Company...
Eli Lilly (LLY) struck a new agreement with Insilico Medicine (ISLMF) that could be worth as much as $2.75 billion, deepening its investment in artificial intel...
Eli Lilly (NYSE:LLY) reported Phase 3b TOGETHER-PsA data showing that Taltz combined with Zepbound outperformed Taltz alone in adults with both active psoriatic...
PPH ETF: Drug Pricing Policy and Eli Lilly Concentration Are the Two Risks to Watch in 2026 By Michael Williams Published Mar 28, 7:15AM EDT Quick Read VanEck...
Eli Lilly And Company (LLY) announced an update on their ongoing clinical study. The Phase 1 trial “A Study of LY4268989 (MORF-057) in Healthy Participants” ai...
Key Points One of these companies' lineup and pipeline within weight management and outside look much stronger. Valuation does not tip the scale in the other'...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.